Udp Glucuronosyltransferases (ugts) - Cancer Science

Relevant Publications

Inhibition of Uridine 5\'-diphospho-glucuronosyltransferases A10 and B7 by vitamins: insights from in silico and in vitro studies.

Issue Release: 2024

Identification of Bromophenols\' glucuronidation and its induction on UDP- glucuronosyltransferases isoforms.

Issue Release: 2024

Identification of novel F-isoprostane metabolites by specific UDP-glucuronosyltransferases.

Issue Release: 2024

Human UDP-glucuronosyltransferase 1As catalyze aristolochic acid D O-glucuronidation to form a lesser nephrotoxic glucuronide.

Issue Release: 2024

Activation of Cryptic Donor Splice Sites Within the UGT1A First-Exon Region Generates Variant Transcripts That Encode UGT1A Proteins With Truncated Aglycone-binding Domains.

Issue Release: 2024

Metabolism characterization and toxicity of N-hydap, a marine candidate drug for lung cancer therapy by LC-MS method.

Issue Release: 2024

Inhibition of human UDP-glucuronosyltransferase (UGT) enzymes by darolutamide: prediction of in vivo drug-drug interactions.

Issue Release: 2024

A web-based scoping review assessing the influence of smoking and smoking cessation on antidiabetic drug meabolism: implications for medication efficacy.

Issue Release: 2024

Inhibition of Human UDP-Glucuronosyltransferase Enzyme by Entrectinib: Implications for Drug-Drug Interactions.

Issue Release: 2024

Efficient Production of Flavonoid Glucuronides in Using Flavonoid -Glucuronosyltransferases Characterized from .

Issue Release: 2024

Identification of the human Cytochrome P450 enzymes (P450s) responsible for metabolizing infigratinib to its pharmacologically active Metabolites, BHS697, and CQM157, and assessment of their in vitro inhibition of P450s and UDP-glucuronosyltransferases (UGTs).

Issue Release: 2024

Pharmacokinetic drug-drug interactions of JBPOS0101 mediated by cytochrome P450 3A4 and UDP-glucuronosyltransferases.

Issue Release: 2024

The potential impact of CYP and UGT drug metabolizing enzymes on brain target site drug exposure.

Issue Release: 2023

Drug-drug interaction potentials of tucatinib inhibition of human UDP-glucuronosyltransferases.

Issue Release: 2023

Hepatic biotransformation of non-psychotropic phytocannabinoids and activity screening on cytochromes P450 and UDP-glucuronosyltransferases.

Issue Release: 2023

Inhibition of aflatoxins on UDP-glucuronosyltransferases (UGTs).

Issue Release: 2023

Heterodimerization of Human UDP-Glucuronosyltransferase 1A9 and UDP-Glucuronosyltransferase 2B7 Alters Their Glucuronidation Activities.

Issue Release: 2023

Crystal Structure Determination of Nucleotide-sugar Binding Domain of Human UDP-glucuronosyltransferases 2B10.

Issue Release: 2023

UDP-glucuronosyltransferase is involved in susceptibility of Chironomus kiiensis Tokunaga, 1936 (Diptera: Chironomidae) to insecticides.

Issue Release: 2023

A Physiologically-Based Pharmacokinetic Model for Cannabidiol in Healthy Adults, Hepatically-Impaired Adults, and Children.

Issue Release: 2023

How Can Patients Access These Treatments?

What Impact Does Lifestyle Have?

What are the Common Imaging Tests Used?

What are the key elements of a patient-centered care plan?

What is the Prognosis for Type IV Cancer?

How is Caliper Matching Implemented?

What are the Challenges in Implementing Reusability?

What are the Advantages of the MTT Assay?

What is Dabrafenib?

Can Lifestyle Changes Help Manage Symptoms?

Udp Glucuronosyltransferases (ugts) - Cancer Science

Relevant Publications

Partnered Content Networks

Relevant Topics